DK Life Science Co., Ltd. (KOSDAQ:303810)

Market Cap	113.06B
Revenue (ttm)	131.17B +0.9%
Net Income	6.73B +23.9%
EPS	379.42 +49.4%
Shares Out	31.98M
PE Ratio	9.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	165,444
Average Volume	148,501
Open	3,630.00
Previous Close	3,635.00
Day's Range	3,515.00 - 3,630.00
52-Week Range	3,330.00 - 8,375.00
Beta	n/a
RSI	47.67
Earnings Date	n/a

About DK Life Science

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally. It offers active pharmaceutical ingredients (API), injection, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instrument. The company was founded in 2017 and is based in Seoul, South Korea.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2017
• Employees: 100
• Stock Exchange: KOSDAQ
• Ticker Symbol: 303810

Financial Performance

In 2024, DK Life Science's revenue was 131.82 billion, an increase of 9.70% compared to the previous year's 120.16 billion. Earnings were 2.24 billion, a decrease of -46.13%.